News Chart BrightPath Biotherapeutics Co., Ltd.

Equities

4594

JP3274140007

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-21 am EDT			5-day change	1st Jan Change
60 ^JPY	+1.69%		+3.45%	-31.03%

2023	BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited	CI
2023	BrightPath Biotherapeutics Co., Ltd. announced that it expects to receive ¥5.1678 million in funding from Macquarie Group Limited	CI

9e86ea4f3c308a8c2a6d66e3aa.uee6Jv-akAz4UvK-WwylcoFJmpQZX7sq6J1HAQwyfqk.063fZ43tz1m9N73NBFvVE7YirqcrD41pg6h_V0dzC-Dris9euKL7eZo3wg~e917e03d4333242e83cd801deaf6c4bb